Cerevel Therapeutics Holdings, Inc.
CERE
주식 순위
#2812
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical firm... Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing treatments for a range of neuroscience disorders. The company boasts a robust pipeline of therapeutic candidates currently undergoing various phases of clinical evaluation. Key assets include emraclidine, a positive allosteric modulator (PAM) in Phase 1b trials for schizophrenia. Another PAM, Darigabat, is being assessed in a Phase 2 proof-of-concept study for drug-resistant focal onset seizures in epilepsy, as well as in a Phase 1 trial for acute anxiety. For Parkinson's disease, Cerevel is advancing Tavapadon, a selective dopamine D1/D5 partial agonist, through Phase 3 clinical trials for both early and late stages of the condition. A related compound, CVL-871, also a selective dopamine D1/D5 partial agonist, is in Phase 2a trials for dementia-related apathy. The company's portfolio further includes CVL-936, a selective dopamine D3-preferring antagonist in Phase I for substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist targeting major depressive disorder and substance use disorder; and CVL-047, a selective PDE4 inhibitor also aimed at major depressive disorder and substance use disorder. Beyond individual compounds, Cerevel is actively developing an M4 agonist program for psychosis and related indications, alongside an LRRK2 inhibitor program designed to address the progression of Parkinson's disease. Founded in 2018, Cerevel Therapeutics is headquartered in Cambridge, Massachusetts.
주가
$44.96
마지막 동기화: 2024-08-01
시가총액
$6.67B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Cerevel Therapeutics Holdings, Inc. (CERE)
카테고리
Healthcare
Cerevel Therapeutics Holdings, Inc. (CERE)의 주식 분할 이력
Cerevel Therapeutics Holdings, Inc. 주식 (심볼: CERE)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Oct 20, 2026에 발생했습니다.
Oct 20, 2026 이전에 매수한 CERE 주식 1주는 현재 0주의 CERE 주식에 해당합니다.
가장 최근의 분할은 Oct 20, 2026에 발생했습니다.
Oct 20, 2026 이전에 매수한 CERE 주식 1주는 현재 0주의 CERE 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 제공된 날짜에 대한 데이터가 충분하지 않습니다. | |||
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
